Thus, our results suggest that aberrantly expressed HSP90 not only regulates BCR signal in CLL cells, it may also regulate the FGFR-signal via stabilization of FGFR3 protein level. Here, FGFR3 is linked to B-cell chronic lymphocytic leukemia.